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Synchronous Colorectal Carcinoma Manifested as Three Separate Colon
Masses: A Case Report and Review of Literature
Alyssa Imperatore, DO. Linda Szczurek, DO, FACOS. Alan Shienbaum, DO

Department of General Surgery, Jefferson Health- NJ Division, Washington Township, NJ
INTRODUCTION

IMAGES

Colorectal cancer is the second leading cause of cancer-related
deaths in the United States amongst cancers that affect both
genders. A small entity of this common disease is synchronous
colorectal carcinoma. Research on this topic is becoming more
prevalent, however, more answers are still needed. Below is a case of
synchronous colorectal carcinoma in which three separate colon
masses were discovered on initial presentation.

CASE PRESENTATION
78 year-old female who presented with shortness of breath on
exertion for two weeks. She complained of associated lightheadedness and a remote history of intermittent black stools but no bright
red blood per rectum or hematemesis. Past medical history
significant for PE currently on Xarelto and left-sided breast cancer
that was treated with neoadjuvant chemotherapy two years prior.
Patient has never had a colonoscopy or EGD. Family history pertinent
for sister dying of stomach cancer 30 years ago but no known history
of inflammatory bowel disease. Physical exam on presentation was
benign with no abdominal tenderness or organomegaly. Vital signs
significant for sinus tachycardia.
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Hemoglobin found to be 5.0 with iron deficiency and heme-occult
positive stool: two units packed red blood cells transfused
Gastroenterology consulted: plan for EGD/colonoscopy
V/Q scan ruled out PE, anticoagulation held for possible GI bleed
Taken to endoscopy suite: three polypoid lesions in rectum and
three separate colon masses located in the cecum, sigmoid colon
and rectosigmoid seen; all of which were biopsied and inked
CT scan post-procedure: 4.2x2.7 cm mass at the cecum in region of
terminal ileum and areas of bowel wall thickening at proximal
descending colon, proximal sigmoid colon, and distal rectosigmoid
colon
General surgery consulted: plan for OR after multidisciplinary
discussion
Pre-operative CEA 2.19
Preliminary pathology: high grade dysplasia in the cecum and
carcinoma in situ in rectal polyp
Taken to the operating room: rectal exam under anesthesia and
laparoscopic subtotal colectomy
Final pathology post-operatively: moderately differentiated invasive
adenocarcinoma arising from tubulovillous adenomas with lymphvascular and perineural invasion, five out of twelve lymph nodes
sampled were involved
Immunohistochemistry stains for mismatch repair proteins: low
probability of microsatellite instability
Uncomplicated post-operative course and stable for discharge on
post-op day four

CT scan abdomen/pelvis with oral and IV contrast: 4.2 x 2.7 cm mass at the cecum in region of terminal
ileum (left). Areas of bowel wall thickening at distal rectosigmoid colon (right).

DISCUSSION
Synchronous colorectal cancer is defined as two or more primary adenocarcinomas
detected within a six-month time frame that are distinctly separate. The overall
incidence has been documented as low as 0.5% and has been reported to be as
high as 8%. This range depends on whether patients with polyposis syndromes or
inflammatory bowel disease are included or not. It has been shown that those
with these disorders have a higher predilection to developing synchronous
colorectal carcinomas, with a common association to microsatellite instability. This
case had a low probability of this factor. Among those with synchronous colorectal
cancer, only less than 15% are patients with three or more primary lesions and the
highest reported tumor count in a single patient thus far is six lesions. Varying data
has been published on factors associated with this presentation. The most
common information states that synchronous tumors appear to occur more with
advanced age. However, these still occur in the middle-aged population.
It can be argued that the most important aspect of synchronous colorectal cancer
is diagnosis. It is common to miss another lesion on imaging or if a full colonoscopy
cannot be completed prior to taking the patient to the operating room. Being able
to inspect the entirety of the bowel is a vital step in determining how to proceed
with treatment, particularly to what extent of surgery to perform.

Colonoscopy: Large spreading masslike lesion in cecum and ascending colon occupying at least half of the
lumen (left). Another large spreading mass lesion over multiple folds in the sigmoid colon, approximately
40 cm from the anal verge (right).

Surgery is a major component of treatment of synchronous colorectal cancer. The
main goal of surgery is an en bloc resection with adequate margins as well as
removing the regional lymph node basin. If this cannot be achieved, palliative
surgery is another option for many patients. There is some controversy over what
procedure a patient should undergo. Some studies conclude that an extended
resection does not improve overall survival, whereas other studies found results
stating that a radical resection can increase survival rate if diagnosed early enough.
Along those lines, a higher risk of post-operative complications and reoperation is
associated with this population. But most importantly, this does not confer a
higher 30-day mortality rate when compared to solitary tumors. Five-year survival
rate has been reported to be as high as 53%, almost equal to that of solitary
tumors. Further research is needed to hone in on the most appropriate surgical
treatment for these multiple lesions.
Follow-up is another key factor in patients with synchronous colorectal carcinoma,
as they are found to have a higher incidence of associated polyps that can undergo
neoplastic transformation and a higher rate of metachronous cancer than those
with single tumors. Therefore, continued management with close follow-up
colonoscopy and imaging is critical in keeping any future progression at bay.

CONCLUSION
Synchronous colorectal cancer may be more prevalent than even documented
secondary to not fully diagnosing or patients undergoing palliative surgery prior to
complete diagnosis. This is a topic that could benefit from a large research
experiment or meta-analysis to better answer the question as to how to effectively
manage these patients.
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Final Pathology (2x magnification): A. Cecal adenocarcinoma invades into muscularis propia (pT2). B.
Splenic flexure adenocarcinoma invades into submucosa (pT1). C. Sigmoid adenocarcinoma invades into
muscularis propria (pT2). D. Lymph node showing metastatic adenocarcinoma. Five of 12 lymph nodes were
positive in the resection specimen.
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